Results 191 to 200 of about 4,732,777 (361)

The OtR tumor recurrence and metastasis model reveals doxorubicin‐induced tumor shrinkage doesn't guarantee prolonged survival

Animal Models and Experimental Medicine, EarlyView.
Tumor growth inhibition does not predict survival benefit in a clinically relevant metastasis model. Tumor local growth and systemic metastasis represent distinct biological processes. In the 4T1‐OtR model, although chemotherapy significantly suppresses primary tumor growth, it fails to prevent distant metastasis or extend overall survival.
Lingli Luo, Ling Liu, Minyao Deng, Yong Jiang, Chuan Liu, Xiang Chen, Xiaoxi Li   +6 more
wiley   +1 more source

Prognostic value of tumor deposits and their different response to neoadjuvant therapy in locally advanced rectal cancer. [PDF]

PLoS One
Zhou D, Zhou J, Hu B, Yu Y, Bian Y, Yang C, Bai Y, Chen H.   +7 more
europepmc   +1 more source

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer [PDF]

, 2007
Oumar Camara, Matthias Rengsberger, A Egbe, André Koch, Mieczysław Gajda, Ulrike Hammer, Cornelia Jörke, C. Rabenstein, Michael Untch, Katharina Pachmann   +9 more
openalex   +1 more source

Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.

Cancer Treatment and Research Communications, 2021
A. Rizzo, G. Brandi
semanticscholar   +1 more source

Population pharmacokinetics and exposure–response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study

British Journal of Clinical Pharmacology, EarlyView.
Aims In the AEGEAN study, perioperative durvalumab plus platinum‐based neoadjuvant chemotherapy for patients with resectable stage II to IIIB (N2) non‐small‐cell lung cancer (NSCLC) demonstrated a favourable benefit–risk profile. This study evaluated population pharmacokinetics (PopPK) and exposure–response (ER) relationships of durvalumab in patients ...
Xiaoying Zhao, Junjie Ding, Jiajia Zhao, Ling Zhang, Aburough Abegesah, Yu‐qian Zhang, Cathy O'Brien, Gary J. Doherty, Allen C. Chen, KyoungSoo Lim, Song Ren, Peiming Ma, Diansong Zhou   +12 more
wiley   +1 more source

Predictive factors for histological response to neoadjuvant therapy in gastric adenocarcinomas. [PDF]

Arq Bras Cir Dig
Bacha D, Boudrigua N, Mallek I, Chammem S, Attia M, Gharbi L, Lahmar A, Ben-Slama S.   +7 more
europepmc   +1 more source

Supplementary Figure 14 from Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy

Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Gabriele Zoppoli, Luc Dirix, Kevin Punie, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne Vincent‐Salomon, Denis Larsimont, Caroline Duhem, Patrice Viens, François Bertucci, Elia Biganzoli, Peter Vermeulen, Giuseppe Floris, Christine Desmedt   +29 more
openalex   +1 more source

Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice. [PDF]

J Cancer Res Clin Oncol
Steike DR, Pepper NB, Gravemeyer S, Bremer A, Glasbrenner B, Brüwer M, Pascher A, Domagk D, Biermann L, Lenz P, Eich HT, Reinartz G.   +11 more
europepmc   +1 more source

Supplementary Figure 4 from Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy

Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Gabriele Zoppoli, Luc Dirix, Kevin Punie, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne Vincent‐Salomon, Denis Larsimont, Caroline Duhem, Patrice Viens, François Bertucci, Elia Biganzoli, Peter Vermeulen, Giuseppe Floris, Christine Desmedt   +29 more
openalex   +1 more source

AKT expression is associated with degree of pathologic response in adenocarcinoma of the esophagus treated with neoadjuvant therapy.

, 2016
Nadia Saeed, Ravi Shridhar, Sarah E. Hoffe, Khaldoun Almhanna, Kenneth Meredith   +4 more
openalex   +1 more source